Hasegawa I - Search Results

1

Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection.

Shinkai N, Tanaka Y, Orito E, Ito K, Ohno T, Hirashima N, Hasegawa I, Sugauchi F, Ueda R, Mizokami M. Shinkai N, et al. Among authors: hasegawa i. Hepatol Res. 2006 Dec;36(4):272-6. doi: 10.1016/j.hepres.2006.08.005. Epub 2006 Sep 12. Hepatol Res. 2006. PMID: 16971173

2

Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection.

Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, Fujiwara K, Ohno T, Ueda R, Mizokami M. Suzuki S, et al. Among authors: hasegawa i. J Gastroenterol Hepatol. 2003 Oct;18(10):1139-43. doi: 10.1046/j.1440-1746.2003.03161.x. J Gastroenterol Hepatol. 2003. PMID: 12974899

3

Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.

Fujiwara K, Tanaka Y, Orito E, Ohno T, Kato T, Sugauchi F, Suzuki S, Hattori Y, Sakurai M, Hasegawa I, Ozasa T, Kanie F, Kano H, Ueda R, Mizokami M. Fujiwara K, et al. Among authors: hasegawa i. J Gastroenterol Hepatol. 2004 Dec;19(12):1343-7. doi: 10.1111/j.1440-1746.2004.03439.x. J Gastroenterol Hepatol. 2004. PMID: 15610306

4

Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C.

Hasegawa I, Orito E, Tanaka Y, Hirashima N, Sakakibara K, Sakurai M, Suzuki S, Sugauchi F, Ohno T, Ueda R, Mizokami M. Hasegawa I, et al. Liver Int. 2005 Apr;25(2):247-53. doi: 10.1111/j.1478-3231.2005.1096.x. Liver Int. 2005. PMID: 15780046

5

A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C.

Orito E, Fujiwara K, Tanaka Y, Yuen MF, Lai CL, Kato T, Sugauchi F, Kusakabe A, Sata M, Okanoue T, Niitsuma H, Sakugawa H, Hasegawa I, Mizokami M. Orito E, et al. Among authors: hasegawa i. Hepatol Res. 2006 Jun;35(2):127-34. doi: 10.1016/j.hepres.2006.03.005. Epub 2006 Apr 19. Hepatol Res. 2006. PMID: 16621686

6

Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus-positive hepatocellular carcinoma.

Ohno T, Hirashima N, Orito E, Hasegawa I, Fujiwara K, Itoh K, Ozasa A, Shinkai N, Tanaka Y, Kato T, Ueda R, Sakakibara K. Ohno T, et al. Among authors: hasegawa i. Hepatol Res. 2007 Apr;37(4):276-85. doi: 10.1111/j.1872-034X.2007.00048.x. Hepatol Res. 2007. PMID: 17397516

7

Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.

Ohno T, Tanaka Y, Sugauchi F, Orito E, Hasegawa I, Nukaya H, Kato A, Matunaga S, Endo M, Tanaka Y, Sakakibara K, Mizokami M. Ohno T, et al. Among authors: hasegawa i. Hepatol Res. 2008 Jul;38(7):683-8. doi: 10.1111/j.1872-034X.2008.00319.x. Epub 2008 Mar 4. Hepatol Res. 2008. PMID: 18328070

8

Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial.

Matsuura K, Tanaka Y, Kusakabe A, Hige S, Inoue J, Komatsu M, Kuramitsu T, Hirano K, Ohno T, Hasegawa I, Kobashi H, Hino K, Hiasa Y, Nomura H, Sugauchi F, Nojiri S, Joh T, Mizokami M. Matsuura K, et al. Among authors: hasegawa i. Hepatol Res. 2011 Jun;41(6):505-11. doi: 10.1111/j.1872-034X.2011.00807.x. Epub 2011 May 18. Hepatol Res. 2011. PMID: 21585626

9

Hepatic Fas protein expression might be a predictive factor for hepatocellular carcinoma development in patients with chronic hepatitis C undergoing interferon therapy.

Hirashima N, Matsumoto Y, Ohono T, Kimura Y, Hasegawa I, Ueda R. Hirashima N, et al. Among authors: hasegawa i. J Clin Gastroenterol. 2002 Mar;34(3):263-7. doi: 10.1097/00004836-200203000-00014. J Clin Gastroenterol. 2002. PMID: 11873109

10

Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies.

Hasegawa I, Tanaka Y, Kramvis A, Kato T, Sugauchi F, Acharya SK, Orito E, Ueda R, Kew MC, Mizokami M. Hasegawa I, et al. J Virol. 2004 Jul;78(14):7575-81. doi: 10.1128/JVI.78.14.7575-7581.2004. J Virol. 2004. PMID: 15220432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters